.On the heels of an FDA turndown for its own chief rival Novo Nordisk, Eli Lilly is pulling ahead in...
.Simply a handful of months after dosing the very first client in a period 2 test for newly detected...
.Eli Lilly's look for weight problems intendeds has actually led it to the black genome. The Big Pha...
.Collection Biosciences is proceeding up. The tissue treatment provider has actually added on $325 m...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted...
.Aelis Farma's hopes of safeguarding an easy, good choice on a $one hundred million option remittanc...
.ProKidney has ceased among a set of period 3 trials for its own tissue treatment for kidney health ...
.Vaxcyte introduced what professionals referred to as "impressive" phase 1/2 data for its 31-valent ...
.Recursion has discovered by means of a very early exam of its tech-enabled technique to drug revela...
.Call it a scenario of really good chemical make up: Acepodia, a biotech based upon Nobel Prize-winn...